[go: up one dir, main page]

WO2013129970A3 - Composition pharmaceutique pour injections possédant une activité vasocontrictive, anticongestive, anti-inflammatoire (et variantes) - Google Patents

Composition pharmaceutique pour injections possédant une activité vasocontrictive, anticongestive, anti-inflammatoire (et variantes) Download PDF

Info

Publication number
WO2013129970A3
WO2013129970A3 PCT/RU2013/000135 RU2013000135W WO2013129970A3 WO 2013129970 A3 WO2013129970 A3 WO 2013129970A3 RU 2013000135 W RU2013000135 W RU 2013000135W WO 2013129970 A3 WO2013129970 A3 WO 2013129970A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical composition
anticongestant
vasoconstricting
inflammatory activity
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/RU2013/000135
Other languages
English (en)
Russian (ru)
Other versions
WO2013129970A2 (fr
Inventor
Владимир Павлович ЛОБКО
Анастасия Геннадьевна ЧЕЛЯЕВА
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2013129970A2 publication Critical patent/WO2013129970A2/fr
Publication of WO2013129970A3 publication Critical patent/WO2013129970A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne les domaines de l'industrie pharmaceutique et de la médecine et peut s'utiliser pour créer et appliquer des compositions pharmaceutiques possédant une activité vasocontrictive, anticongestive, anti-inflammatoire lors de rhinites aigues, de processus inflammatoires des antres maxillaires du nez, de saignements du nez et de conjonctivite. L'invention vise une préparation pharmaceutique à base de naphazoline grâce à l'inclusion dans la composition pharmaceutique de substances minérales, de remplacement dans la composition pharmaceutique des isotopes de carbone 12С pharmaceutique par des isotopes de carbone 13С.
PCT/RU2013/000135 2012-02-29 2013-02-20 Composition pharmaceutique pour injections possédant une activité vasocontrictive, anticongestive, anti-inflammatoire (et variantes) Ceased WO2013129970A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EA201200211 2012-02-29
EA201200211A EA021295B1 (ru) 2012-02-29 2012-02-29 Фармацевтический состав, обладающий сосудосуживающим, антиконгестивным, противовоспалительным действием (варианты)

Publications (2)

Publication Number Publication Date
WO2013129970A2 WO2013129970A2 (fr) 2013-09-06
WO2013129970A3 true WO2013129970A3 (fr) 2013-11-14

Family

ID=48916289

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2013/000135 Ceased WO2013129970A2 (fr) 2012-02-29 2013-02-20 Composition pharmaceutique pour injections possédant une activité vasocontrictive, anticongestive, anti-inflammatoire (et variantes)

Country Status (2)

Country Link
EA (1) EA021295B1 (fr)
WO (1) WO2013129970A2 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2156087C1 (ru) * 1999-11-25 2000-09-20 Товарищество с ограниченной ответственностью Фирма "Электронная медицина" Биологически активная добавка
RU2251417C2 (ru) * 2003-04-11 2005-05-10 Аникеев Сергей Владимирович Средство для лечения гайморита "антигайморит"
RU2281086C1 (ru) * 2005-01-18 2006-08-10 Сергей Николаевич Анисимов Глазные антигистаминные капли
RU2412188C2 (ru) * 2006-09-21 2011-02-20 Раквалиа Фарма Инк. Производные бензимидазола в качестве селективных ингибиторов кислотной помпы

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3470131B2 (ja) * 1994-03-16 2003-11-25 大正製薬株式会社 持効性点鼻剤
US20050080043A1 (en) * 2000-09-20 2005-04-14 Lee Shahinian Self-preserved antibacterial nasal, inhalable, and topical ophthalmic preparations and medications

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2156087C1 (ru) * 1999-11-25 2000-09-20 Товарищество с ограниченной ответственностью Фирма "Электронная медицина" Биологически активная добавка
RU2251417C2 (ru) * 2003-04-11 2005-05-10 Аникеев Сергей Владимирович Средство для лечения гайморита "антигайморит"
RU2281086C1 (ru) * 2005-01-18 2006-08-10 Сергей Николаевич Анисимов Глазные антигистаминные капли
RU2412188C2 (ru) * 2006-09-21 2011-02-20 Раквалиа Фарма Инк. Производные бензимидазола в качестве селективных ингибиторов кислотной помпы

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Registr lekarstvennykh sredstv Rossii.", RLS-APTEKAR. GI. RED. G.L. VYSHKOVSKY VYPUSK, vol. 5, 2003, pages 702 - 703 *
"Tekhnologia lekarstvennykh form.", POD RED. T.S. KONDRATEVOI, TOM 1, M., ''MEDITSINA, 1991, pages 364 *

Also Published As

Publication number Publication date
EA201200211A1 (ru) 2013-07-30
EA021295B1 (ru) 2015-05-29
WO2013129970A2 (fr) 2013-09-06

Similar Documents

Publication Publication Date Title
TN2012000549A1 (en) Substituted 5-fluoro-1h-pyrazolopyridines and use thereof
HK1206779A1 (en) Modified polynucleotides for the production of nuclear proteins
GT201200250A (es) Ariltriazolonas ligadas a bisarilo y su uso
WO2012106407A3 (fr) Procédés diagnostiques et thérapeutiques et produits liés aux troubles de l'anxiété
PH12013501143A1 (en) Substituted 1-benzylcycloalkylcarboxlic acids and use thereof
TN2016000022A1 (en) Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core
TN2013000529A1 (en) Trpm8 antagonists and their use in treatments
WO2011141685A3 (fr) Compositions nasales a visee systemique a base de cocoyl proline ou d'au moins un de ses constituants
SG11201600318RA (en) Novel indolizine derivatives, method for the production thereof and pharmaceutical compositions containing same
NZ702930A (en) Racecadotril liquid compositions
WO2014203275A3 (fr) Procédé amélioré pour la préparation d'apixaban et de ses intermédiaires
EP4410369A3 (fr) Composition pour application nasale a stabilite amelioree
MX2015000179A (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
EP2732028A4 (fr) Compositions et procédés pour la production d'isoprène
IL237688A0 (en) A syringe containing a preparation, in particular a pharmaceutical preparation containing immunoglobulins, a method for its production and use
TR201009167A2 (tr) Sefalosporin içeren farmasötik granüller.
MX360047B (es) Unidad sólida con alto contenido en fexofenadina y su procedimiento de preparación.
UY34743A (es) Composición farmacéutica tópica, proceso de producción de la composición farmacéutica tópica, uso de la composición farmacéutica tópica y método de tratamiento tópico de psoriasis, dermatitis atópica o eczemas crónicos
EP2871209A4 (fr) Particules composites de sulfate de baryum, composition de résine les comprenant, et leur procédé de production
BR112014025972A8 (pt) monocloridratos de anamorelina, composições, processo para preparar monocloridrato de anamorelina, método para produzir uma forma de dosagem farmacêutica e forma de dosagem farmacêutica oral
ATE481393T1 (de) Neue cycloalkyl-benzothiadiazin-derivate, ihr herstellungsverfahren und die pharmazeutischen zusammensetzungen, die sie enthalten
EP2983684B8 (fr) Huile essentielle et aloès pour le traitement et la prophylaxie d'inflammations provoquées par demodex, notamment la blépharite marginale, composition pharmaceutique contenant une huile essentielle et/ou de l'aloès et utilisation de l'huile essentielle et de l'aloès et de leurs compositions pour la production d'une préparation utilisée dans le traitement et la prophylaxie des inflammations mentionnées
BR112014011745A2 (pt) composição farmacêutica, e, processo para a fabricação de uma composição farmacêutica de hidrocortisona
BR112013015501A2 (pt) composto, composição farmacêutica, métodos para tratamento de infecções virais e de distúrbios inflamatórios, e, processo para produzir uma sangliferrina mutassintética
WO2013129970A3 (fr) Composition pharmaceutique pour injections possédant une activité vasocontrictive, anticongestive, anti-inflammatoire (et variantes)

Legal Events

Date Code Title Description
122 Ep: pct application non-entry in european phase

Ref document number: 13755365

Country of ref document: EP

Kind code of ref document: A2